Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR 1,635 crores
Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23
Categories
pharmaceuticals
Panacea Biotech Q1FY23 Net profit soars by 2%
Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores
Balaxi Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Q&A Highlights: [00:06:25] Archana Gude with IDBI asked about the sustainable
SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/G2_d7tTye3s Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked about the
Top 5 Stocks with 200% Profit Growth in 2022
1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in 1946 by
Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/l4VNZKKcWGw Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer update and
Aurobindo Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/b8g7f6BUs9Y Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: [00:08:34] Prakash Agarwal of Axis Capital asked about
Shilpa Medicare Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/4rB2G3iK3UE Key highlights from Shilpa Medicare Ltd (SHILPAMED) Q1 FY23 Earnings Concall Q&A Highlights: Vineet Gala of Monarch Networth asked about the
Marksans Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/9PAJ7vTTG5E Key highlights from Marksans Pharma Limited (MARKSANS) Q1 FY23 Earnings Concall Management Update: MARKSANS said it aims to increase its R&D
Supriya Lifescience Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/LNBcyeiXX0U Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q1 FY23 Earnings Concall Management Update: SUPRIYA said the company is extending its backward
Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Transcript
Balaxi Pharmaceuticals Ltd (NSE:BALAXI) Q1 FY23 Earnings Concall dated Aug. 18, 2022 Corporate Participants: Ashish Maheshwari -- Managing Director Pranav Maheshwari --
SMS Pharmaceuticals Limited (SMSPHARMA) Q2 FY23 Earnings Concall Transcript
SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Q2 FY23 Earnings Concall Aug. 18, 2022 Corporate Participants: P. Vamsi Krishna -- Executed Director LakshminarayanaTammineedi -- Chief
Aurobindo Pharma Limited Q1 FY 2023 Research Tear Sheet
Stock Data Ticker: AUROPHARMA Exchange :NSE and BSE Industry: Automobile Price Performance Last 7 days 4.36% YTD -19.19% Last 12 months -28.17%
Divi’s Laboratories Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/EPaxfKgyoZQ Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q1 FY23 Earnings Concall Q&A Highlights: Tushar Manudhane from Motilal Oswal asked about the
Aarti Industries Ltd Q1 FY23 Earnings Conference Call Insights
https://youtu.be/CUmhEBZpLC0 Key highlights from Aarti Industries Ltd (AARTIIND) Q1 FY23 Earnings Concall Management Update: [00:05:18] AARTIIND said it has started seeing volume
Aarti Industries reported stellar performance in Q1FY23, Revenue up by 45%
On Wednesday, Aarti Industry reported its earnings for the quarter ended June 30, 2022. The revenue from operations (gross) grew by 45%
Glenmark Life Sciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America
JB Chemicals & Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
Key highlights from JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q1 FY23 Earnings Concall Q&A Highlights: Rahul Jeewani from IIFL Securities asked about
CAPLIN POINT LABORATORIES LTD (CAPPL) Q2 FY22 Earnings Concall Transcript
CAPLIN POINT LABORATORIES LTD (NSE:CAPPL) Q2 FY22 Earnings Concall dated Aug. 05, 2022 Corporate Participants: Vivek Paarthipan -- Chief Operating Officer M.
Lupin Ltd (LUPIN) Q1 FY23 Earnings Concall Transcript
Lupin Ltd (NSE: LUPIN) Q1 FY23 Earnings Concall dated Aug. 04, 2022 Corporate Participants: Kamal Kishore Sharma -- Vice Chairman of the
Earnings Infographic: Dr. Lal PathLabs Q1 2023 revenue and profit decline
Dr. Lal PathLabs Ltd (NSE: LALPATHLAB), a leading provider of diagnostic and related healthcare services, has reported lower revenues and earnings for